LVW Advisors LLC Purchases 187 Shares of Intuitive Surgical, Inc. $ISRG

LVW Advisors LLC lifted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 12.1% in the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,736 shares of the medical equipment provider’s stock after acquiring an additional 187 shares during the period. LVW Advisors LLC’s holdings in Intuitive Surgical were worth $943,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Chilton Capital Management LLC raised its stake in Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 43 shares during the last quarter. Global Financial Private Client LLC raised its stake in Intuitive Surgical by 253.3% during the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider’s stock valued at $26,000 after buying an additional 38 shares during the last quarter. Elite Financial Inc. purchased a new position in Intuitive Surgical during the first quarter valued at $26,000. LFA Lugano Financial Advisors SA purchased a new position in Intuitive Surgical during the first quarter valued at $30,000. Finally, TD Capital Management LLC raised its stake in Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 45 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on ISRG shares. Truist Financial lifted their price objective on Intuitive Surgical from $590.00 to $600.00 and gave the company a “buy” rating in a research note on Wednesday, July 23rd. Wells Fargo & Company lifted their price objective on Intuitive Surgical from $559.00 to $599.00 and gave the company an “overweight” rating in a research note on Wednesday, July 23rd. Wall Street Zen lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Friday. BTIG Research lifted their target price on Intuitive Surgical from $566.00 to $571.00 and gave the stock a “buy” rating in a report on Wednesday, July 23rd. Finally, Piper Sandler reissued an “overweight” rating and issued a $595.00 target price (up previously from $575.00) on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Thirteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus price target of $595.95.

Intuitive Surgical Price Performance

Shares of ISRG opened at $441.12 on Friday. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00. The firm has a market capitalization of $158.13 billion, a P/E ratio of 61.52, a PEG ratio of 4.59 and a beta of 1.61. The business has a fifty day moving average of $469.43 and a 200 day moving average of $501.46.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The company had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. During the same quarter in the previous year, the company posted $1.78 earnings per share. Intuitive Surgical’s revenue was up 21.4% compared to the same quarter last year. Analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Buying and Selling

In related news, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction on Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the sale, the insider owned 19,827 shares of the company’s stock, valued at $9,368,059.23. The trade was a 59.69% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Amy L. Ladd sold 335 shares of Intuitive Surgical stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $440.69, for a total value of $147,631.15. Following the completion of the sale, the director directly owned 739 shares of the company’s stock, valued at $325,669.91. The trade was a 31.19% decrease in their position. The disclosure for this sale can be found here. Insiders sold 45,224 shares of company stock valued at $21,716,492 over the last 90 days. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.